tetano
Editor, Senior Moderator
ACS Nano
. 2020 Oct 1.
doi: 10.1021/acsnano.0c06109. Online ahead of print.
Engineering Antiviral Vaccines
Xingwu Zhou[SUP] 1 2 3 [/SUP], Xing Jiang[SUP] 4 [/SUP], Moyuan Qu[SUP] 5 [/SUP], George E Aninwene 2nd[SUP] 1 2 [/SUP], Vadim Jucaud[SUP] 6 [/SUP], James J Moon[SUP] 3 [/SUP], Zhen Gu[SUP] 1 2 7 8 [/SUP], Wujin Sun[SUP] 1 2 7 6 [/SUP], Ali Khademhosseini[SUP] 1 2 9 7 8 10 6 [/SUP]
Affiliations
Abstract
Despite the vital role of vaccines in fighting viral pathogens, effective vaccines are still unavailable for many infectious diseases. The importance of vaccines cannot be overstated during the outbreak of a pandemic, such as the coronavirus disease 2019 (COVID-19) pandemic. The understanding of genomics, structural biology, and innate/adaptive immunity have expanded the toolkits available for current vaccine development. However, sudden outbreaks and the requirement of population-level immunization still pose great challenges in today's vaccine designs. Well-established vaccine development protocols from previous experiences are in place to guide the pipelines of vaccine development for emerging viral diseases. Nevertheless, vaccine development may follow different paradigms during a pandemic. For example, multiple vaccine candidates must be pushed into clinical trials simultaneously, and manufacturing capability must be scaled up in early stages. Factors from essential features of safety, efficacy, manufacturing, and distributions to administration approaches are taken into consideration based on advances in materials science and engineering technologies. In this review, we present recent advances in vaccine development by focusing on vaccine discovery, formulation, and delivery devices enabled by alternative administration approaches. We hope to shed light on developing better solutions for faster and better vaccine development strategies through the use of biomaterials, biomolecular engineering, nanotechnology, and microfabrication techniques.
Keywords: COVID-19; biomedical devices; drug delivery; drug discovery; immunotherapy; infectious disease; pandemics; vaccine.
. 2020 Oct 1.
doi: 10.1021/acsnano.0c06109. Online ahead of print.
Engineering Antiviral Vaccines
Xingwu Zhou[SUP] 1 2 3 [/SUP], Xing Jiang[SUP] 4 [/SUP], Moyuan Qu[SUP] 5 [/SUP], George E Aninwene 2nd[SUP] 1 2 [/SUP], Vadim Jucaud[SUP] 6 [/SUP], James J Moon[SUP] 3 [/SUP], Zhen Gu[SUP] 1 2 7 8 [/SUP], Wujin Sun[SUP] 1 2 7 6 [/SUP], Ali Khademhosseini[SUP] 1 2 9 7 8 10 6 [/SUP]
Affiliations
- PMID: 33001626
- DOI: 10.1021/acsnano.0c06109
Abstract
Despite the vital role of vaccines in fighting viral pathogens, effective vaccines are still unavailable for many infectious diseases. The importance of vaccines cannot be overstated during the outbreak of a pandemic, such as the coronavirus disease 2019 (COVID-19) pandemic. The understanding of genomics, structural biology, and innate/adaptive immunity have expanded the toolkits available for current vaccine development. However, sudden outbreaks and the requirement of population-level immunization still pose great challenges in today's vaccine designs. Well-established vaccine development protocols from previous experiences are in place to guide the pipelines of vaccine development for emerging viral diseases. Nevertheless, vaccine development may follow different paradigms during a pandemic. For example, multiple vaccine candidates must be pushed into clinical trials simultaneously, and manufacturing capability must be scaled up in early stages. Factors from essential features of safety, efficacy, manufacturing, and distributions to administration approaches are taken into consideration based on advances in materials science and engineering technologies. In this review, we present recent advances in vaccine development by focusing on vaccine discovery, formulation, and delivery devices enabled by alternative administration approaches. We hope to shed light on developing better solutions for faster and better vaccine development strategies through the use of biomaterials, biomolecular engineering, nanotechnology, and microfabrication techniques.
Keywords: COVID-19; biomedical devices; drug delivery; drug discovery; immunotherapy; infectious disease; pandemics; vaccine.